(20371917), S. K. (2025). Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells.
Dyfyniad Arddull Chicago(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Dyfyniad MLA(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.